Scientists uncovered how childhood BK virus infections may set off cancer-causing mutations decades later: by activating a host immune system enzyme that attacks DNA.

Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based Vincere Cancer Center has launched recruitment for clinical testing to evaluate the ...

The mRNA synthesis and manufacturing market's potential lies in the increasing demand for mRNA therapeutics and vaccines, driven by COVID-19 successes. Opportunities include mRNA custom synthesis and ...

Gov. Ron DeSantis and Surgeon General Joseph Ladapo have called for a complete repeal of Florida’s vaccine mandate. Ladapo ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

The universal features that define genomic regions acting as replication origins remain unclear. In this study, we mapped a set of origins in Trypanosoma brucei using stranded short nascent strand ...

Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ResearchAndMarkets.com's offering. The ...